{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:40:48Z","timestamp":1790700048470,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jaut.2020.102465","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T08:03:33Z","timestamp":1587456213000},"page":"102465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Identification of Ribosomal Protein S4, Y-Linked 1 as a cyclosporin A plus corticosteroid resistance gene"],"prefix":"10.1016","volume":"112","author":[{"given":"Rui","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangxiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aize","family":"Kijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2020.102465_bib1","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1001\/jama.1977.03280220040018","article-title":"Corticosteroid treatment in systemic lupus erythematosus. Survival studies","volume":"238","author":"Urman","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2020.102465_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrrheum.2013.157","article-title":"Pragmatic approaches to therapy for systemic lupus erythematosus","volume":"10","author":"Xiong","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102465_bib3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/annrheumdis-2016-210711","article-title":"Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"76","author":"Chatzidionysiou","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102465_bib4","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2020.102465_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1572-0241.2007.01653.x","article-title":"Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis","volume":"103","author":"Cacheux","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2020.102465_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001651","article-title":"Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on managing modifiable risk in transplantation (COMMIT) group","volume":"101","author":"Neuberger","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jaut.2020.102465_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.autrev.2013.01.004","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"12","author":"Greco","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102465_bib8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.autrev.2014.01.023","article-title":"Diagnosis and classification of Vogt-Koyanagi-Harada disease","volume":"13","author":"Sakata","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102465_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13023-016-0412-4","article-title":"Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes","volume":"11","author":"Lavezzo","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaut.2020.102465_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2009.08.030","article-title":"Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease","volume":"117","author":"Rao","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2020.102465_bib11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ophtha.2006.07.040","article-title":"Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients","volume":"114","author":"Yang","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2020.102465_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.preteyeres.2016.02.002","article-title":"Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment","volume":"52","author":"Du","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jaut.2020.102465_bib13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaophthalmol.2018.2664","article-title":"Development and evaluation of diagnostic criteria for vogt-koyanagi-harada disease","volume":"136","author":"Yang","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaut.2020.102465_bib14","first-page":"899","article-title":"[T lymphocyte subsets in aqueous humor from patients with uveitis]","volume":"100","author":"Ohta","year":"1996","journal-title":"Nippon. Ganka Gakkai Zasshi"},{"key":"10.1016\/j.jaut.2020.102465_bib15","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1167\/iovs.05-1547","article-title":"Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens","volume":"47","author":"Sugita","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2020.102465_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/bjophthalmol-2014-306106","article-title":"Specific association of IL17A genetic variants with panuveitis","volume":"99","author":"Mucientes","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102465_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2007.01.010","article-title":"IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease","volume":"119","author":"Chi","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102465_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.autrev.2016.04.001","article-title":"Vogt-Koyanagi-Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options","volume":"15","author":"Silpa-Archa","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102465_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archopht.1991.01080050096037","article-title":"Clinical course, therapy, and long-term visual outcome","volume":"109","author":"Rubsamen","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102465_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","article-title":"syndrome","volume":"39","author":"Moorthy","year":"1995","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102465_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-200604620-00011","article-title":"Vogt-Koyanagi-Harada disease","volume":"46","author":"Andreoli","year":"2006","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.jaut.2020.102465_bib22","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1111\/aos.12648","article-title":"Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease","volume":"93","author":"Urzua","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102465_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09273940500536766","article-title":"Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy","volume":"14","author":"Paredes","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jaut.2020.102465_bib24","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1111\/aos.12127","article-title":"Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids","volume":"91","author":"Abu El-Asrar","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102465_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.clim.2008.12.007","article-title":"Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome","volume":"131","author":"Liu","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102465_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102465_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809982","article-title":"Chlorambucil targets BRCA1\/2-deficient tumours and counteracts PARP inhibitor resistance","volume":"11","author":"Tacconi","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jaut.2020.102465_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-3083.1987.tb01074.x","article-title":"Characterization of leukotriene B4-omega-hydroxylase activity within human polymorphonuclear granulocytes","volume":"25","author":"Brom","year":"1987","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2020.102465_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/bjophthalmol-2017-311079","article-title":"MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease","volume":"102","author":"Chang","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102465_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2148-8-142","article-title":"RPS4Y gene family evolution in primates","volume":"8","author":"Andres","year":"2008","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.jaut.2020.102465_bib31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/02713680500263606","article-title":"Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China","volume":"30","author":"Yang","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jaut.2020.102465_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41591-019-0424-4","article-title":"Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial","volume":"25","author":"Rodon","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2020.102465_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007071","article-title":"Profiling RNA-Seq at multiple resolutions markedly increases the number of causal eQTLs in autoimmune disease","volume":"13","author":"Odhams","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jaut.2020.102465_bib34","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1634\/theoncologist.12-10-1225","article-title":"Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas","volume":"12","author":"Tabernero","year":"2007","journal-title":"Oncol."},{"key":"10.1016\/j.jaut.2020.102465_bib35","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1158\/1078-0432.CCR-10-1300","article-title":"Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data","volume":"17","author":"Jung","year":"2011","journal-title":"Clin. Canc. Res. : Off. J. Am. Assoc. Canc. Res."},{"key":"10.1016\/j.jaut.2020.102465_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/ol.2017.6137","article-title":"Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma","volume":"14","author":"Kuang","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jaut.2020.102465_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/HYPERTENSIONAHA.117.10250","article-title":"Dysregulated expression of RPS4Y1 (ribosomal protein S4, Y-linked 1) impairs STAT3 (signal transducer and activator of transcription 3) signaling to suppress trophoblast cell migration and invasion in preeclampsia","volume":"71","author":"Chen","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jaut.2020.102465_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13075-019-1894-y","article-title":"RNA sequencing of mesenchymal stem cells reveals a blocking of differentiation and immunomodulatory activities under inflammatory conditions in rheumatoid arthritis patients","volume":"21","author":"Lamas","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102465_bib39","series-title":"ACP Journal Club. Prednisolone plus chlorambucil preserved renal function in membranous nephropathy","volume":"158","author":"Remuzzi","year":"2013"},{"key":"10.1016\/j.jaut.2020.102465_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199208273270904","article-title":"Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group","volume":"327","author":"Ponticelli","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2020.102465_bib41","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199805213382104","article-title":"Chlorambucil in indolent chronic lymphocytic leukemia. French cooperative group on chronic lymphocytic leukemia","volume":"338","author":"Dighiero","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2020.102465_bib42","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(15)60027-7","article-title":"Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial","volume":"385","author":"Hillmen","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2020.102465_bib43","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1200\/JCO.2013.49.6547","article-title":"Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: final analysis of an open-label phase II study","volume":"32","author":"Hillmen","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jaut.2020.102465_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3476(78)80031-6","article-title":"Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome","volume":"92","author":"Guesry","year":"1978","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2020.102465_bib45","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0140-6736(92)90098-N","article-title":"Chlorambucil infertility and sperm banking","volume":"339","author":"Brahams","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2020.102465_bib46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.ASN.0000053420.37216.9E","article-title":"Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum","volume":"14","author":"Stoenoiu","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2020.102465_bib47","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.bbrc.2018.07.014","article-title":"Differential expression of cyclosporine A-Induced calcineurin isoform-specific matrix metalloproteinase 9 (MMP-9) in renal fibroblasts","volume":"503","author":"Francis","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120300810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120300810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:24:46Z","timestamp":1760257486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841120300810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":47,"alternative-id":["S0896841120300810"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102465","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Ribosomal Protein S4, Y-Linked 1 as a cyclosporin A plus corticosteroid resistance gene","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102465"}}